GT Healthcare Capital Partners
Venture Capital
Active
Hong Kong, China
24
55M
13
2.67
4
0.46
- Stages of investment
- Areas of investment
Summary
In 2015 was created GT Healthcare Capital Partners, which is appeared as VC. The main department of described VC is located in the Hong Kong. The fund was located in Asia if to be more exact in Hong Kong.
The fund was created by Alan Au. Besides them, we counted 4 critical employees of this fund in our database.
The important activity for fund was in 2019. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from GT Healthcare Capital Partners is more than 1 billion dollars.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Oxford Nanopore Technologies, Oxford VR, Ultromics. The fund has specific favorite in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GT Healthcare Capital Partners, startups are often financed by Venrock, Sofinnova Partners, Pfizer Venture Investments. The meaningful sponsors for the fund in investment in the same round are Sonder Capital, Oxford Sciences Innovation, Vertex Ventures. In the next rounds fund is usually obtained by Oxford Finance LLC, Hostplus, GIC.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 24
- Lead investments
- 4
- Rounds per year
- 2.67
- Follow on index
- 0.46
- Investments by industry
- Health Care (20)
- Biotechnology (16)
- Artificial Intelligence (7)
- Medical Device (7)
- Therapeutics (6) Show 14 more
- Investments by region
-
- United Kingdom (12)
- United States (8)
- France (2)
- China (2)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 247M
- Group Appearance index
- 0.92
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
GT Apeiron Therapeutics | 11 Jun 2019 | Biotechnology, Health Care, Therapeutics | Seed | 27M | Shanghai, China |
WayRabbit | 01 Mar 2016 | Logistics, Information Technology, Mobile, Delivery, Shipping | Seed | United States, New York, New York | |
Potrero Medical | 09 Jul 2018 | Biotechnology, Artificial Intelligence, Health Care, Medical Device, Medical | Late Stage Venture | 26M | United States, California, Hayward |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.